{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:40:36Z","timestamp":1790404836097,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2022MH041"],"award-info":[{"award-number":["ZR2022MH041"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR202102181004"],"award-info":[{"award-number":["ZR202102181004"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81500553"],"award-info":[{"award-number":["81500553"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82100791"],"award-info":[{"award-number":["82100791"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-025-02650-0","type":"journal-article","created":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T10:34:24Z","timestamp":1752489264000},"page":"2499-2509","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Dapagliflozin ameliorates high glucose-induced epithelial-mesenchymal transition via up-regulating ACE2 mediated by EZH2 in diabetic nephropathy"],"prefix":"10.1007","volume":"48","author":[{"given":"Simeng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nannan","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqiang","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinglian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6340-3662","authenticated-orcid":false,"given":"Ying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,14]]},"reference":[{"issue":"Suppl 1","key":"2650_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/dom.14007","volume":"22","author":"NM Selby","year":"2020","unstructured":"Selby NM, Taal MW (2020) An updated overview of diabetic nephropathy: diagnosis, prognosis, treatment goals and latest guidelines. DIABETES OBES METAB 22(Suppl 1):3\u201315","journal-title":"DIABETES OBES METAB"},{"key":"2650_CR2","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/978-981-13-8871-2_4","volume":"1165","author":"LF Zeng","year":"2019","unstructured":"Zeng LF, Xiao Y, Sun L (2019) A glimpse of the mechanisms related to renal fibrosis in diabetic nephropathy. ADV EXP MED BIOL 1165:49\u201379","journal-title":"ADV EXP MED BIOL"},{"key":"2650_CR3","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/s42003-020-1008-z","volume":"3","author":"Q Yan","year":"2020","unstructured":"Yan Q, Zhu K, Zhang L et al (2020) A negative feedback loop between JNK-associated leucine zipper protein and TGF-beta1 regulates kidney fibrosis. COMMUN BIOL 3:288","journal-title":"COMMUN BIOL"},{"key":"2650_CR4","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/978-3-319-51436-9_13","volume":"60","author":"AS Cruz-Solbes","year":"2017","unstructured":"Cruz-Solbes AS, Youker K (2017) Epithelial to mesenchymal transition (EMT) and endothelial to mesenchymal transition (EndMT): role and implications in kidney fibrosis. Results Probl Cell Differ 60:345\u2013372","journal-title":"Results Probl Cell Differ"},{"key":"2650_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-4939-9841-8_1","volume":"2067","author":"MK Sagoo","year":"2020","unstructured":"Sagoo MK, Gnudi L (2020) Diabetic nephropathy: an overview. Methods Mol Biol 2067:3\u20137","journal-title":"Methods Mol Biol"},{"key":"2650_CR6","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","volume":"383","author":"H Heerspink","year":"2020","unstructured":"Heerspink H, Stefansson BV, Correa-Rotter R et al (2020) Dapagliflozin in patients with chronic kidney disease. NEW ENGL J MED 383:1436\u20131446","journal-title":"NEW ENGL J MED"},{"key":"2650_CR7","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","volume":"380","author":"V Perkovic","year":"2019","unstructured":"Perkovic V, Jardine MJ, Neal B et al (2019) Canagliflozin and renal outcomes in type 2 diabetes and nephropathy. NEW ENGL J MED 380:2295\u20132306","journal-title":"NEW ENGL J MED"},{"key":"2650_CR8","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1042\/CS20210094","volume":"135","author":"KN Miyata","year":"2021","unstructured":"Miyata KN, Lo CS, Zhao S et al (2021) Angiotensin II up-regulates sodium-glucose co-transporter 2 expression and SGLT2 inhibitor attenuates Ang II-induced hypertensive renal injury in mice. CLIN SCI 135:943\u2013961","journal-title":"CLIN SCI"},{"key":"2650_CR9","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1053\/j.ajkd.2013.03.018","volume":"62","author":"SJ Taler","year":"2013","unstructured":"Taler SJ, Agarwal R, Bakris GL et al (2013) KDOQI US commentary on the 2012 KDIGO clinical practice guideline for management of blood pressure in CKD. AM J KIDNEY DIS 62:201\u2013213","journal-title":"AM J KIDNEY DIS"},{"key":"2650_CR10","doi-asserted-by":"crossref","unstructured":"Fletcher RA, Jongs N, Chertow GM et al (2023) Effect of SGLT2 inhibitors on discontinuation of Renin-angiotensin system blockade: A joint analysis of the CREDENCE and DAPA-CKD trials. J Am Soc Nephrol 34:1965-1975","DOI":"10.1681\/ASN.0000000000000248"},{"key":"2650_CR11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.31083\/j.fbl2901017","volume":"29","author":"R Li","year":"2024","unstructured":"Li R, Li F, Yuan L (2024) ACE2 regulates glycolipid metabolism in multiple tissues. FRONT BIOSCI-LANDMRK 29:17","journal-title":"FRONT BIOSCI-LANDMRK"},{"key":"2650_CR12","first-page":"3008","volume":"22","author":"Z Chen","year":"2020","unstructured":"Chen Z, Chen X, Bai Y, Diao Z, Liu W (2020) Angiotensinconverting enzyme2 improves diabetic nephropathy by targeting Smad7 for ubiquitin degradation. MOL MED REP 22:3008\u20133016","journal-title":"MOL MED REP"},{"key":"2650_CR13","doi-asserted-by":"publisher","first-page":"102674","DOI":"10.1016\/j.redox.2023.102674","volume":"62","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Fan X, Wang Q et al (2023) ROS promote hyper-methylation of NDRG2 promoters in a DNMTS-dependent manner: contributes to the progression of renal fibrosis. REDOX BIOL 62:102674","journal-title":"REDOX BIOL"},{"key":"2650_CR14","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/ejhf.1432","volume":"21","author":"J McMurray","year":"2019","unstructured":"McMurray J, DeMets DL, Inzucchi SE et al (2019) A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor Dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF). EUR J HEART FAIL 21:665\u2013675","journal-title":"EUR J HEART FAIL"},{"key":"2650_CR15","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/S2213-8587(19)30180-9","volume":"7","author":"O Mosenzon","year":"2019","unstructured":"Mosenzon O, Wiviott SD, Cahn A et al (2019) Effects of Dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE-TIMI 58 randomised trial. LANCET DIABETES ENDO 7:606\u2013617","journal-title":"LANCET DIABETES ENDO"},{"key":"2650_CR16","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jchf.2021.11.006","volume":"10","author":"SD Solomon","year":"2022","unstructured":"Solomon SD, Vaduganathan M, Claggett BL et al (2022) Baseline characteristics of patients with HF with mildly reduced and preserved ejection fraction: DELIVER trial. JACC-HEART FAIL 10:184\u2013197","journal-title":"JACC-HEART FAIL"},{"key":"2650_CR17","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.kint.2021.03.033","volume":"100","author":"DC Wheeler","year":"2021","unstructured":"Wheeler DC, Toto RD, Stefansson BV et al (2021) A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of Dapagliflozin on major adverse kidney events in patients with IgA nephropathy. KIDNEY INT 100:215\u2013224","journal-title":"KIDNEY INT"},{"key":"2650_CR18","doi-asserted-by":"publisher","first-page":"121671","DOI":"10.1016\/j.lfs.2023.121671","volume":"322","author":"L Feng","year":"2023","unstructured":"Feng L, Chen Y, Li N et al (2023) Dapagliflozin delays renal fibrosis in diabetic kidney disease by inhibiting YAP\/TAZ activation. LIFE SCI 322:121671","journal-title":"LIFE SCI"},{"key":"2650_CR19","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ijcard.2021.05.029","volume":"336","author":"XT Li","year":"2021","unstructured":"Li XT, Zhang MW, Zhang ZZ et al (2021) Abnormal apelin-ACE2 and SGLT2 signaling contribute to adverse cardiorenal injury in patients with COVID-19. INT J CARDIOL 336:123\u2013129","journal-title":"INT J CARDIOL"},{"key":"2650_CR20","doi-asserted-by":"publisher","first-page":"e241534","DOI":"10.1371\/journal.pone.0241534","volume":"15","author":"N Maksimowski","year":"2020","unstructured":"Maksimowski N, Williams VR, Scholey JW (2020) Kidney ACE2 expression: implications for chronic kidney disease. PLoS ONE 15:e241534","journal-title":"PLoS ONE"},{"key":"2650_CR21","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1093\/ndt\/gft320","volume":"28","author":"MJ Soler","year":"2013","unstructured":"Soler MJ, Wysocki J, Batlle D (2013) ACE2 alterations in kidney disease. NEPHROL DIAL TRANSPL 28:2687\u20132697","journal-title":"NEPHROL DIAL TRANSPL"},{"key":"2650_CR22","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.2147\/DDDT.S252351","volume":"14","author":"S Li","year":"2020","unstructured":"Li S, Li Y, Xu H et al (2020) ACE2 attenuates Epithelial-Mesenchymal transition in MLE-12 cells induced by silica. Drug Des Devel Ther 14:1547\u20131559","journal-title":"Drug Des Devel Ther"},{"key":"2650_CR23","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.semcancer.2022.09.004","volume":"86","author":"JH Lee","year":"2022","unstructured":"Lee JH, Massague J (2022) TGF-beta in developmental and fibrogenic EMTs. SEMIN CANCER BIOL 86:136\u2013145","journal-title":"SEMIN CANCER BIOL"},{"key":"2650_CR24","doi-asserted-by":"publisher","first-page":"13093","DOI":"10.1111\/jcmm.15914","volume":"24","author":"J Ni","year":"2020","unstructured":"Ni J, Yang F, Huang XR et al (2020) Dual deficiency of angiotensin-converting enzyme-2 and Mas receptor enhances angiotensin II-induced hypertension and hypertensive nephropathy. J CELL MOL MED 24:13093\u201313103","journal-title":"J CELL MOL MED"},{"key":"2650_CR25","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12929-023-00965-9","volume":"30","author":"CW Wang","year":"2023","unstructured":"Wang CW, Chuang HC, Tan TH (2023) ACE2 in chronic disease and COVID-19: gene regulation and post-translational modification. J BIOMED SCI 30:71","journal-title":"J BIOMED SCI"},{"key":"2650_CR26","doi-asserted-by":"publisher","first-page":"e13685","DOI":"10.1111\/eci.13685","volume":"52","author":"AG Izquierdo","year":"2022","unstructured":"Izquierdo AG, Carreira MC, Boughanem H et al (2022) Adipose tissue and blood leukocytes ACE2 DNA methylation in obesity and after weight loss. EUR J CLIN INVEST 52:e13685","journal-title":"EUR J CLIN INVEST"},{"key":"2650_CR27","doi-asserted-by":"publisher","first-page":"7344","DOI":"10.1038\/s41467-022-35059-x","volume":"13","author":"A Verma","year":"2022","unstructured":"Verma A, Singh A, Singh MP et al (2022) EZH2-H3K27me3 mediated KRT14 upregulation promotes TNBC peritoneal metastasis. NAT COMMUN 13:7344","journal-title":"NAT COMMUN"},{"key":"2650_CR28","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.bbrc.2020.04.010","volume":"526","author":"Y Li","year":"2020","unstructured":"Li Y, Li H, Zhou L (2020) EZH2-mediated H3K27me3 inhibits ACE2 expression. BIOCHEM BIOPH RES CO 526:947\u2013952","journal-title":"BIOCHEM BIOPH RES CO"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-025-02650-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-025-02650-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-025-02650-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:40:32Z","timestamp":1760362832000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-025-02650-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,14]]},"references-count":28,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["2650"],"URL":"https:\/\/doi.org\/10.1007\/s40618-025-02650-0","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,14]]},"assertion":[{"value":"1 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study involving animals met the Animals in Research Reporting In Vivo Experiments (ARRIVE) guidelines and followed the guidelines of the National Institutes of Health guide. All experiments were approved by the hospital ethics committees of Shandong Provincial Hospital Affiliated to Shandong First Medical University (No. 2020-070).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication was obtained from all the listed authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors report there are no competing interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Completing interests"}},{"value":"This article does not contain any studies with human participants performed by any of the authors.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants"}},{"value":"For this type of study informed consent is not required.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}